First human test for new drug formula begins
NCT ID NCT07364851
Summary
This is an early safety study to see how the body processes two different versions of an experimental drug called DW4421. It will involve 38 healthy adult volunteers who will each receive both drug versions in a specific order. The main goals are to check for side effects and measure how much of the drug gets into the bloodstream and how long it stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chungbuk National University Hospital
Cheongju-si, South Korea
Conditions
Explore the condition pages connected to this study.